Notifications
Back
High-Precision Radiation Therapy

Excellence
In Oncology

We pioneer the future of cancer treatment with
Magnetic Precision Radiation Therapy (MPRT).

RADEXEL Logo

RADEXEL represents the convergence of Radiation and Excellence.

We are setting a new paradigm in cancer treatment by developing magnetic-controlled radiation therapy systems,

powered by the world’s first magnetic-radiation fusion technology and AI-driven precision treatment planning.

WHO WE ARE

Innovating the Future of Cancer Treatment


Radexel is pioneering a fusion solution that combines radiation therapy with advanced magnetic control technology.
We are building an optimized medical device ecosystem tailored to diverse clinical needs: the 'Modular Add-on (MPRT-SD)' for upgrading existing systems,
the 'Integrated All-in-One (MPRT-IS)' for complete treatment solutions,
and the 'Robotic System (MPRT-RB)' for precise, targeted therapy.

Cost Efficiency & Accessibility
Maximizing Efficiency

We aim to resolve the challenges of high acquisition costs and limited efficiency associated with modern radiation therapy systems. High costs often restrict patient access to necessary treatments. Radexel is driving technological innovation to enhance cost-efficiency, creating an environment where more patients can receive timely and effective care.

Precision & Safety
Targeting via Magnetic Control

Our Magnetic-Radiation Fusion Technology controls the path and distribution of radiation beams using magnetic fields. This system is designed to concentrate the radiation dose precisely on the tumor while minimizing exposure to surrounding healthy organs. We aim to deliver superior precision compared to conventional methods while alleviating the economic burden on patients.

Technology Leadership
Robust IP Portfolio & Validation

Radexel holds the world’s largest portfolio of foundational patents in magnetic-radiation fusion therapy. We have successfully completed prototype development and pre-clinical validation, proving the feasibility of our technology. As a global frontrunner, we are now focused on refining and advancing this cutting-edge technology.

Up to
0%*
Dose Reduction Healthy Tissue Sparing
 
0+
Global Patents Core Patents Held
 
0M+
Total Funding($) Investment & R&D Grants
* Dose reduction data is based on phantom studies and pre-clinical trials comparing Radexel’s magnetic control technology with conventional photon beam therapy (IMRT).

WHAT WE MADE

Products Powered by 

Magnetic Precision Radiation Therapy Technology 

MPRT-Module
MPRT-Module
Modular Add-on Solution
Extends the capabilities of existing radiotherapy systems. Its modular design is compatible with standard equipment, enabling an immediate functional upgrade without replacing the machine.
MPRT-System
MPRT-System
Integrated All-in-One System
An integrated system. The radiation source and the magnetic field control module are built as one unit, designed to deliver precision treatment from the moment of installation.
MPRT-Robot
MPRT-Robot
Mobile Robotic System
A robotic treatment system free from spatial constraints. Its compact design and mobility enable precise, localized treatment in a range of clinical settings, including the operating room.
* The RADEXEL products introduced on this page are medical devices currently under development. They are in the process of, or preparing for, major regulatory approvals (FDA, CE, MFDS, etc.).

Research & Development

PIPELINE

Radexel is dedicated to advancing technology that prioritizes safety  and comfort for both patients and medical professionals. 

Planning
Feasibility
Development
Validation
Approval
MPRT-Module
Regulatory stage
MPRT-Robot
Development stage
MPRT-System
Development stage